CVS Caremark (CVS) Tops Q3 Views by 1c
More News related to CVS
- The Brualdi Law Firm, P.C. Announces Class Action Lawsuit Against CVS Caremark Corporation
- Humana and CVS Caremark's MinuteClinic Expand Member Access to Convenient Quality Care
- MinuteClinic Opens First Retail Clinic in Washington, D.C. at CVS/pharmacy Store in Northeast
- Brower Piven Encourages Investors Who Have Losses in Excess of $300,000 From Investment in CVS Caremark Corporation to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsui
- CVS/pharmacy Kicks Off Annual Thanks and Giving(R) Campaign for the St. Jude Children's Research Hospital
More News related to Earnings
- Financial Group Moving Higher Amid BofA TARP Repayment News (BAC, C, WFC, XLF, FAS)
- Lexington Realty Trust (LXP) Sells Office Facility in Columbia, SC
- BofA (BAC) Confirms That It Will Repay $45B in TARP Funds
- EQT Corp.'s (EQT) Board Approves Capital Budget for 2010
- Morgan Stanley (MS) may restructure its real estate fund -WSJ
CVS Caremark Corporation (NYSE: CVS) reports Q3 EPS of $0.65, 1 cent better than the analyst estimate of $0.64. Revenue for the quarter was $24.60 billion, which compares to the estimate of $24.61 billion.
Related Categories
EarningsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
